chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Vaccination site pain
Clinical narrative: Itchiness at left upper arm; Redness at left upper arm; Swelling of left upper arm; Pain at injection site; This spontaneous case was reported by a non-health professional and describes the occurrence of PRURITUS (Itchiness at left upper arm), ERYTHEMA (Redness at left upper arm), PERIPHERAL SWELLING (Swelling of left upper arm) and VACCINATION SITE PAIN (Pain at injection site) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced VACCINATION SITE PAIN (Pain at injection site). On 13-Aug-2021, the patient experienced PRURITUS (Itchiness at left upper arm), ERYTHEMA (Redness at left upper arm) and PERIPHERAL SWELLING (Swelling of left upper arm). On 06-Aug-2021, VACCINATION SITE PAIN (Pain at injection site) had resolved. At the time of the report, PRURITUS (Itchiness at left upper arm), ERYTHEMA (Redness at left upper arm) and PERIPHERAL SWELLING (Swelling of left upper arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient called in to report about her experience after receiving first dose of Moderna vaccine. She said she had pain at injection site for 3 days and then it went away. Her concern was that just last Friday, 13 Aug 2021, she started to had itchiness on her arm, redness, and swelling which all happened on her upper arm. She thought that she was having an allergic reaction and afraid to get the second dose.  Concomitant and treatment medications were not reported.   Reporter did not allow further contact
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Pain in extremity, Pruritus, Rash erythematous
Clinical narrative: developed a skin condition. It feels like a sun burn and affects his arms, hands, and face.; Sometimes it itches and it usually happens after he eats; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS ( developed a skin condition. It feels like a sun burn and affects his arms, hands, and face.), PRURITUS (Sometimes it itches and it usually happens after he eats) and PAIN IN EXTREMITY (sore arm) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A20A and 039A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high and Diabetes.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Feb-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (sore arm). On an unknown date, the patient experienced RASH ERYTHEMATOUS ( developed a skin condition. It feels like a sun burn and affects his arms, hands, and face.) and PRURITUS (Sometimes it itches and it usually happens after he eats). At the time of the report, RASH ERYTHEMATOUS ( developed a skin condition. It feels like a sun burn and affects his arms, hands, and face.), PRURITUS (Sometimes it itches and it usually happens after he eats) and PAIN IN EXTREMITY (sore arm) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) Normal.         Patient could not remember the concomitant medications.  No treatment medications were reported.   This case was linked to MOD-2021-014619 (Patient Link).
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Redness; pain in the injection site for several days; swelling in the injection site for several days; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (pain in the injection site for several days) and VACCINATION SITE SWELLING (swelling in the injection site for several days) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness), VACCINATION SITE PAIN (pain in the injection site for several days) and VACCINATION SITE SWELLING (swelling in the injection site for several days). At the time of the report, VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (swelling in the injection site for several days) had resolved and VACCINATION SITE PAIN (pain in the injection site for several days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were provided by the reporter.  No treatment medication were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 23-Aug-2021: Follow up received contains reporter details, first dose information and additional event of redness added.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Fatigue, Headache
Clinical narrative: Dizzy; Shortness of breath; major headache; Fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Aug-2021 and was forwarded to Moderna on 17-Aug-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy), DYSPNOEA (Shortness of breath), HEADACHE (major headache) and FATIGUE (Fatigue) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 044A12A) for COVID-19 vaccination.     Concomitant products included ELECTROLYTES NOS, GLUCOSE (PEDIALYTE [ELECTROLYTES NOS;GLUCOSE]) for an unknown indication.   On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Feb-2021, the patient experienced DIZZINESS (Dizzy), DYSPNOEA (Shortness of breath), HEADACHE (major headache) and FATIGUE (Fatigue). At the time of the report, DIZZINESS (Dizzy), DYSPNOEA (Shortness of breath), HEADACHE (major headache) and FATIGUE (Fatigue) outcome was unknown.            Treatment medication were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: I had a severe rxn . I have only half of 1 kidney total. After second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (I had a severe rxn . I have only half of 1 kidney total. After second vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Solitary kidney (I have only half of 1 kidney total).   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (I had a severe rxn . I have only half of 1 kidney total. After second vaccine). At the time of the report, VACCINATION COMPLICATION (I had a severe rxn . I have only half of 1 kidney total. After second vaccine) outcome was unknown.          No Concomitant use were reported.  No Treatment were reported
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: mixed normal saline with Moderna COVID19 vial; This spontaneous case was reported by a consumer and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (mixed normal saline with Moderna COVID19 vial) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 17-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (mixed normal saline with Moderna COVID19 vial). On 17-Aug-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (mixed normal saline with Moderna COVID19 vial) had resolved.            No concomitant medications information was reported. No treatment medications were provided. It was reported that the patient was not experiencing any symptoms and was monitored for 15 minutes.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Accidental overdose
Clinical narrative: Patient received 1ml instead of .5ml; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Patient received 1ml instead of .5ml) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 milliliter. On 17-Aug-2021, the patient experienced ACCIDENTAL OVERDOSE (Patient received 1ml instead of .5ml). On 17-Aug-2021, ACCIDENTAL OVERDOSE (Patient received 1ml instead of .5ml) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 17-year-old  patient received the first dose of Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old  patient received the first dose of Moderna COVID-19 vaccine) in a 17-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027C21A) for COVID-19 vaccination.     No Medical History information was reported.  On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old  patient received the first dose of Moderna COVID-19 vaccine). On 29-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (17-year-old  patient received the first dose of Moderna COVID-19 vaccine) had resolved.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  It was reported that, patient accidently received the Moderna vaccine while he was meant to be administered with the Pfizer vaccine.  Treatment information was not provided.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Hypoaesthesia, Nasopharyngitis, Pruritus
Clinical narrative: hand itches; Face became numb; She was not feeling good; Fever 104.9F; She was tired; she was Cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (she was Cold), PRURITUS (hand itches), HYPOAESTHESIA (Face became numb), FEELING ABNORMAL (She was not feeling good) and PYREXIA (Fever 104.9F) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A, 011L20A and 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Epstein Barr virus positive mucocutaneous ulcer (Epstein Barr Virus). Concurrent medical conditions included Drug allergy (If she takes Valtrex 1 gram twice a day her hand itches). Concomitant products included VITAMIN D NOS for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced NASOPHARYNGITIS (she was Cold), PYREXIA (Fever 104.9F) and FATIGUE (She was tired). On an unknown date, the patient experienced PRURITUS (hand itches), HYPOAESTHESIA (Face became numb) and FEELING ABNORMAL (She was not feeling good). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency; VALACICLOVIR HYDROCHLORIDE (VALTREX) at a dose of 1 gram and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. On 14-Feb-2021, NASOPHARYNGITIS (she was Cold) and PYREXIA (Fever 104.9F) had resolved. On 15-Feb-2021, FATIGUE (She was tired) had resolved. At the time of the report, PRURITUS (hand itches), HYPOAESTHESIA (Face became numb) and FEELING ABNORMAL (She was not feeling good) had resolved.            Treatment medication included Tylenol and Advil and Fluids, Valtrex, (A-Eb-H6)  All side effects  lasted for 48 hours. She was tired for a day after fever went away.  She now is taking Valtrex 1gram daily. If she takes Valtrex 1 gram twice a day her hand itches.  She tried a Natural supplement: (A-Eb-H6)  for  two days before started Valtrex. This supplement was stopped.  On an unknown date in Feb-2021, the patient was positive for Epstein Barr Virus test after second shot      This case was linked to MOD-2021-289692, MOD-2021-290616 (Patient Link).
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: hand itches; Face became numb; She was not feeling good; Fever 104.9F; She was tired; she was Cold; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (she was Cold), PRURITUS (hand itches), HYPOAESTHESIA (Face became numb), FEELING ABNORMAL (She was not feeling good) and PYREXIA (Fever 104.9F) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A, 011L20A and 002F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Epstein Barr virus positive mucocutaneous ulcer (Epstein Barr Virus). Concurrent medical conditions included Drug allergy (If she takes Valtrex 1 gram twice a day her hand itches). Concomitant products included VITAMIN D NOS for an unknown indication.   On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced NASOPHARYNGITIS (she was Cold), PYREXIA (Fever 104.9F) and FATIGUE (She was tired). On an unknown date, the patient experienced PRURITUS (hand itches), HYPOAESTHESIA (Face became numb) and FEELING ABNORMAL (She was not feeling good). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency; VALACICLOVIR HYDROCHLORIDE (VALTREX) at a dose of 1 gram and IBUPROFEN (ADVIL [IBUPROFEN]) for Fever, at an unspecified dose and frequency. On 14-Feb-2021, NASOPHARYNGITIS (she was Cold) and PYREXIA (Fever 104.9F) had resolved. On 15-Feb-2021, FATIGUE (She was tired) had resolved. At the time of the report, PRURITUS (hand itches), HYPOAESTHESIA (Face became numb) and FEELING ABNORMAL (She was not feeling good) had resolved.            Treatment medication included Tylenol and Advil and Fluids, Valtrex, (A-Eb-H6)  All side effects  lasted for 48 hours. She was tired for a day after fever went away.  She now is taking Valtrex 1gram daily. If she takes Valtrex 1 gram twice a day her hand itches.  She tried a Natural supplement: (A-Eb-H6)  for  two days before started Valtrex. This supplement was stopped.  On an unknown date in Feb-2021, the patient was positive for Epstein Barr Virus test after second shot      This case was linked to MOD-2021-289692, MOD-2021-290616 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pyrexia
Clinical narrative: dizziness; fever; headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), PYREXIA (fever) and HEADACHE (headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), PYREXIA (fever) and HEADACHE (headache). At the time of the report, DIZZINESS (dizziness), PYREXIA (fever) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No medical history was reported. No concomitant treatment was reported. Patient had a fever, headache and dizziness about 48 hours after the shot.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache
Clinical narrative: Moderna shot has messed me up I do not feel right ever since; head hurts really bad; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Moderna shot has messed me up I do not feel right ever since) and HEADACHE (head hurts really bad) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING ABNORMAL (Moderna shot has messed me up I do not feel right ever since) and HEADACHE (head hurts really bad). At the time of the report, FEELING ABNORMAL (Moderna shot has messed me up I do not feel right ever since) and HEADACHE (head hurts really bad) had not resolved.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant medications were reported.  No treatment medications were reported.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Arm soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     Concomitant products included MIRTAZAPINE (REMERON), CLONAZEPAM, LEVOTHYROXINE, TAMSULOSIN, PANTOPRAZOLE, HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/APAP) and ROSUVASTATIN for an unknown indication.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm soreness). On 27-Jan-2021, PAIN IN EXTREMITY (Arm soreness) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment information was not provided. Patient reported that in trying to get a third dose on 17AUG2021 the patient accidentally received a dose of the Pfizer COVID-19 vaccine   This case was linked to MOD-2021-289836 (Patient Link).
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: sore right injection site shoulder; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore right injection site shoulder) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (sore right injection site shoulder). At the time of the report, VACCINATION SITE PAIN (sore right injection site shoulder) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medications were not provided. Treatment information was not provided.   This case was linked to MOD-2021-289841 (Patient Link).
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Illness, Impaired work ability, Nausea
Clinical narrative: ill for a day; loss of appetite; he had to take off work because he did not feel good; chills; nauseous; overwhelming feeling like he would puke; fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill for a day), DECREASED APPETITE (loss of appetite), IMPAIRED WORK ABILITY (he had to take off work because he did not feel good), CHILLS (chills) and NAUSEA (nauseous) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for an unknown indication.   On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Aug-2021, the patient experienced ILLNESS (ill for a day), DECREASED APPETITE (loss of appetite), IMPAIRED WORK ABILITY (he had to take off work because he did not feel good), CHILLS (chills), NAUSEA (nauseous), VOMITING (overwhelming feeling like he would puke) and PYREXIA (fever). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 dosage form. At the time of the report, ILLNESS (ill for a day), DECREASED APPETITE (loss of appetite), IMPAIRED WORK ABILITY (he had to take off work because he did not feel good), CHILLS (chills), NAUSEA (nauseous), VOMITING (overwhelming feeling like he would puke) and PYREXIA (fever) outcome was unknown.            This case was linked to MOD-2021-289744 (Patient Link).
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Vomiting
Clinical narrative: ill for a day; loss of appetite; he had to take off work because he did not feel good; chills; nauseous; overwhelming feeling like he would puke; fever; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill for a day), DECREASED APPETITE (loss of appetite), IMPAIRED WORK ABILITY (he had to take off work because he did not feel good), CHILLS (chills) and NAUSEA (nauseous) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 007C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Hypertension. Concomitant products included LISINOPRIL for an unknown indication.   On 16-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Aug-2021, the patient experienced ILLNESS (ill for a day), DECREASED APPETITE (loss of appetite), IMPAIRED WORK ABILITY (he had to take off work because he did not feel good), CHILLS (chills), NAUSEA (nauseous), VOMITING (overwhelming feeling like he would puke) and PYREXIA (fever). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 dosage form. At the time of the report, ILLNESS (ill for a day), DECREASED APPETITE (loss of appetite), IMPAIRED WORK ABILITY (he had to take off work because he did not feel good), CHILLS (chills), NAUSEA (nauseous), VOMITING (overwhelming feeling like he would puke) and PYREXIA (fever) outcome was unknown.            This case was linked to MOD-2021-289744 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: 8 months between the first and second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (8 months between the first and second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (8 months between the first and second dose). In August 2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (8 months between the first and second dose) had resolved.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site movement impairment, Vaccination site pain
Clinical narrative: After receiving the first dose the same night my arm started hurting; I couldn't move it I had to move it with my right hand; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (After receiving the first dose the same night my arm started hurting) and VACCINATION SITE MOVEMENT IMPAIRMENT (I couldn't move it I had to move it with my right hand) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037Z20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included METOPROLOL SUCCINATE (TOPROL), OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), LISINOPRIL (ZESTRIL), RANOLAZINE (RANEXA), CHLORTHALIDONE, AMLODIPINE BESILATE (NORVASC) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced VACCINATION SITE PAIN (After receiving the first dose the same night my arm started hurting) and VACCINATION SITE MOVEMENT IMPAIRMENT (I couldn't move it I had to move it with my right hand). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (After receiving the first dose the same night my arm started hurting) and VACCINATION SITE MOVEMENT IMPAIRMENT (I couldn't move it I had to move it with my right hand) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment also included applying heat.   This case was linked to MOD-2021-289854 (Patient Link).
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site pain
Clinical narrative: The pain travels up to the shoulder and when I'm picking up an object during the pain I drop the object; It hurt my arm when I received it it started hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (The pain travels up to the shoulder and when I'm picking up an object during the pain I drop the object) and VACCINATION SITE PAIN (It hurt my arm when I received it it started hurting) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 037Z20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included METOPROLOL SUCCINATE (TOPROL), OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), LISINOPRIL (ZESTRIL), RANOLAZINE (RANEXA), CHLORTHALIDONE, AMLODIPINE BESILATE (NORVASC) and ACETYLSALICYLIC ACID (ASPIRIN 81) for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Feb-2021, the patient experienced PAIN (The pain travels up to the shoulder and when I'm picking up an object during the pain I drop the object) and VACCINATION SITE PAIN (It hurt my arm when I received it it started hurting). At the time of the report, PAIN (The pain travels up to the shoulder and when I'm picking up an object during the pain I drop the object) and VACCINATION SITE PAIN (It hurt my arm when I received it it started hurting) had not resolved.            No treatment medication information was provided.   This case was linked to MOD-2021-289851 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Mobility decreased, Pyrexia
Clinical narrative: Had a hard time moving; Felt like a train hit her; Shaking chills; Fever; This spontaneous case was reported by a pharmacist and describes the occurrence of MOBILITY DECREASED (Had a hard time moving), FEELING ABNORMAL (Felt like a train hit her), CHILLS (Shaking chills) and PYREXIA (Fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.  Concomitant products included THYROID, EZETIMIBE, SIMVASTATIN (VYTORIN), ESOMEPRAZOLE SODIUM (NEXIUM [ESOMEPRAZOLE SODIUM]) and FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication.   On 09-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Feb-2021, the patient experienced MOBILITY DECREASED (Had a hard time moving), FEELING ABNORMAL (Felt like a train hit her), CHILLS (Shaking chills) and PYREXIA (Fever). At the time of the report, MOBILITY DECREASED (Had a hard time moving), FEELING ABNORMAL (Felt like a train hit her), CHILLS (Shaking chills) and PYREXIA (Fever) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.
Age: 47.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: She received her first 2 doses from Pfizer and her 3rd dose from Moderna; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (She received her first 2 doses from Pfizer and her 3rd dose from Moderna) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 05-Apr-2021, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 25-Apr-2021, received second dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) dosage was changed to 1 dosage form. On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Aug-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (She received her first 2 doses from Pfizer and her 3rd dose from Moderna). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (She received her first 2 doses from Pfizer and her 3rd dose from Moderna) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided by the reporter.  No treatment medication were provided by the reporter.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling abnormal, Headache, Illness, Pain
Clinical narrative: got the first Moderna COVID-19 shot in in Mar2021/did not get the second shot; whole body sore; She got the first Moderna COVID-19 shot and got so terribly sick; felt like I had COVID again; chills; fever; headache; Arm super super achy; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (got the first Moderna COVID-19 shot in in Mar2021/did not get the second shot), PAIN (whole body sore), ILLNESS (She got the first Moderna COVID-19 shot and got so terribly sick), FEELING ABNORMAL (felt like I had COVID again) and CHILLS (chills) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concomitant products included ENALAPRIL for an unknown indication.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN (whole body sore), ILLNESS (She got the first Moderna COVID-19 shot and got so terribly sick), FEELING ABNORMAL (felt like I had COVID again), CHILLS (chills), PYREXIA (fever), HEADACHE (headache) and VACCINATION SITE PAIN (Arm super super achy). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (got the first Moderna COVID-19 shot in in Mar2021/did not get the second shot). In March 2021, PAIN (whole body sore), ILLNESS (She got the first Moderna COVID-19 shot and got so terribly sick), FEELING ABNORMAL (felt like I had COVID again), CHILLS (chills), PYREXIA (fever), HEADACHE (headache) and VACCINATION SITE PAIN (Arm super super achy) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (got the first Moderna COVID-19 shot in in Mar2021/did not get the second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that for the adverse events patient took Tylenol or Advil, she does not remember which as treatment. The symptoms resolved after 24 hours.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Pyrexia, Vaccination site pain
Clinical narrative: got the first Moderna COVID-19 shot in in Mar2021/did not get the second shot; whole body sore; She got the first Moderna COVID-19 shot and got so terribly sick; felt like I had COVID again; chills; fever; headache; Arm super super achy; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (got the first Moderna COVID-19 shot in in Mar2021/did not get the second shot), PAIN (whole body sore), ILLNESS (She got the first Moderna COVID-19 shot and got so terribly sick), FEELING ABNORMAL (felt like I had COVID again) and CHILLS (chills) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 in November 2020. Concomitant products included ENALAPRIL for an unknown indication.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, the patient experienced PAIN (whole body sore), ILLNESS (She got the first Moderna COVID-19 shot and got so terribly sick), FEELING ABNORMAL (felt like I had COVID again), CHILLS (chills), PYREXIA (fever), HEADACHE (headache) and VACCINATION SITE PAIN (Arm super super achy). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (got the first Moderna COVID-19 shot in in Mar2021/did not get the second shot). In March 2021, PAIN (whole body sore), ILLNESS (She got the first Moderna COVID-19 shot and got so terribly sick), FEELING ABNORMAL (felt like I had COVID again), CHILLS (chills), PYREXIA (fever), HEADACHE (headache) and VACCINATION SITE PAIN (Arm super super achy) had resolved. At the time of the report, PRODUCT DOSE OMISSION ISSUE (got the first Moderna COVID-19 shot in in Mar2021/did not get the second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that for the adverse events patient took Tylenol or Advil, she does not remember which as treatment. The symptoms resolved after 24 hours.
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired dose received on 29Jul2021, Vaccine syringe was given chance to warm up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired dose received on 29Jul2021, Vaccine syringe was given chance to warm up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired dose received on 29Jul2021, Vaccine syringe was given chance to warm up). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired dose received on 29Jul2021, Vaccine syringe was given chance to warm up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The HCP received the shipment of Moderna multi-dose vials on 22Jul2021 and stated that her team was new to the multi-dose vials and stated that 3 doses were administered to the patients after vaccine vial was expired and this was the first time this occurred and did not have any such previous incidences.   Storage condition before administration: Fridge  Taken out of Fridge drawn up and put back, syringe was given chance to warm up a bit while waiting on the patients and there were no visual changes of vaccine. And there was one vial that was impacted.  Refrigerated expiration date was 22-Aug-2021 and vial placed into fridge from freezer was 22-Jul-2021 however desired use by date within 24 hours of opening.  Max temperature: 41 degrees Fahrenheit with average temperature of 39.8 degrees Fahrenheit, Minimum: 38.6 degrees Fahrenheit. These were all temperatures of the fridge in Fahrenheit.   4 doses were administered from the vial.  Date vial was punctured: 28Jul2021  Total of 3 doses were administered after the vial was expired.   Unable to provide patient identifiers information and additional information about the patients but stated that total of 3 patients were affected after being given 3 doses from same vial after it was expired. These were 1st doses of Moderna vaccine for all 3 patients.   The caller stated that 2 of the patients were husband and wife who received the expired vaccine.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue, Urinary tract infection
Clinical narrative: Second Dose not received in allowed time window; Urinary Tract Infection; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second Dose not received in allowed time window) and URINARY TRACT INFECTION (Urinary Tract Infection) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second Dose not received in allowed time window) and URINARY TRACT INFECTION (Urinary Tract Infection). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second Dose not received in allowed time window) had resolved and URINARY TRACT INFECTION (Urinary Tract Infection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided by the reporter.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pain in extremity, Pyrexia, Rash
Clinical narrative: The third day after the shot, she had a  head to toe rash; joint pain; extreme fatigue; low grade fever; back of her legs felt like fire like she had a hot poker in her leg; This spontaneous case was reported by an other health care professional and describes the occurrence of PAIN IN EXTREMITY (back of her legs felt like fire like she had a hot poker in her leg), RASH (The third day after the shot, she had a  head to toe rash), ARTHRALGIA (joint pain), FATIGUE (extreme fatigue) and PYREXIA (low grade fever) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (back of her legs felt like fire like she had a hot poker in her leg), ARTHRALGIA (joint pain), FATIGUE (extreme fatigue) and PYREXIA (low grade fever). On 28-Jan-2021, the patient experienced RASH (The third day after the shot, she had a  head to toe rash). At the time of the report, PAIN IN EXTREMITY (back of her legs felt like fire like she had a hot poker in her leg), RASH (The third day after the shot, she had a  head to toe rash), ARTHRALGIA (joint pain), FATIGUE (extreme fatigue) and PYREXIA (low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. She had titanium in her back and legs.  Treatment information was not provided.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Rash macular
Clinical narrative: Blotches all over his body arms, legs and crotch/ blotches again appeared; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Blotches all over his body arms, legs and crotch/ blotches again appeared) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced RASH MACULAR (Blotches all over his body arms, legs and crotch/ blotches again appeared). In 2021, RASH MACULAR (Blotches all over his body arms, legs and crotch/ blotches again appeared) had resolved.            No concomitant medications were provided.  The patient had taken both his doses through their local county health department.  The patient went to the emergency room and was given steroid injectable form but he was advised to take it orally. The blotches did not resolve so he went to his doctor who prescribed him with an oral steroid over a 2 week period. He stated that it took 2-4 weeks before the blotches went away.   This case was linked to MOD-2021-290082 (Patient Link).
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Euphoric mood
Clinical narrative: 15 minutes after shot, felt high for about an hour; This spontaneous case was reported by a consumer and describes the occurrence of EUPHORIC MOOD (15 minutes after shot, felt high for about an hour) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Aug-2021, the patient experienced EUPHORIC MOOD (15 minutes after shot, felt high for about an hour). At the time of the report, EUPHORIC MOOD (15 minutes after shot, felt high for about an hour) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication or treatment information was provided.   Reporter did not allow further contact
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Amnesia, Depression, Fatigue, Feeling abnormal, Muscle spasms
Clinical narrative: Cramps all over (mainly in leg and feet at night); Brain fog; Depression; Tremors; Memory loss; 24 to 36 hours after vaccination had a sever reaction; Chronic fatigue (after walks); Muscle pain (comes on at night or hour after walk); This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (Cramps all over (mainly in leg and feet at night)), FEELING ABNORMAL (Brain fog), DEPRESSION (Depression), TREMOR (Tremors) and AMNESIA (Memory loss) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LOTEPREDNOL ETABONATE (LOTREL [LOTEPREDNOL ETABONATE]), ROSUVASTATIN CALCIUM (CRESTOR) and ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.   On 14-Feb-2001, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MUSCLE SPASMS (Cramps all over (mainly in leg and feet at night)), FEELING ABNORMAL (Brain fog), DEPRESSION (Depression), TREMOR (Tremors), AMNESIA (Memory loss), VACCINATION COMPLICATION (24 to 36 hours after vaccination had a sever reaction), FATIGUE (Chronic fatigue (after walks)) and MYALGIA (Muscle pain (comes on at night or hour after walk)). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, MUSCLE SPASMS (Cramps all over (mainly in leg and feet at night)), FEELING ABNORMAL (Brain fog), DEPRESSION (Depression), TREMOR (Tremors), AMNESIA (Memory loss), FATIGUE (Chronic fatigue (after walks)) and MYALGIA (Muscle pain (comes on at night or hour after walk)) had not resolved and VACCINATION COMPLICATION (24 to 36 hours after vaccination had a sever reaction) had resolved.            This case was linked to MOD-2021-289860 (Patient Link).